TrialPloS one2015

Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial.

Amélie Anota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.